Investing.com - Redhill ADR reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Redhill ADR announced earnings per share of $-0.060 on revenue of $17.6M. Analysts polled by Investing.com anticipated EPS of $-0.020 on revenue of $23.19M.
Redhill ADR shares are down 85.47% from the beginning of the year and are trading at $0.351 , down-from-52-week-high.
Redhill ADR shares lost 6.40% in pre-market trade following the report.
Redhill ADR follows other major Healthcare sector earnings this month
Redhill ADR's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of $1.98 on revenue of $6.94B, compared to forecasts EPS of $1.91 on revenue of $6.91B.
Pfizer had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.78 on revenue of $22.6B, compared to forecast for EPS of $1.44 on revenue of $21.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar